Aligos Therapeutics, Inc. ALGS Q3 2025 earnings

FAQ

When did Aligos Therapeutics, Inc. report Q3 2025 earnings?

Aligos Therapeutics, Inc. (ALGS) reported Q3 2025 earnings on November 6, 2025 before market open.

What were Aligos Therapeutics, Inc.'s Q3 2025 revenue and EPS?

Aligos Therapeutics, Inc. reported revenue of $741.0K and eps of $-3.04 for Q3 2025.

Did Aligos Therapeutics, Inc. beat estimates in Q3 2025?

Revenue beat the consensus estimate of $266.7K by $474.3K. EPS missed the consensus estimate of $-2.09 by $0.95.

How did Aligos Therapeutics, Inc.'s Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 41.6% from $1.3M a year earlier and eps grew 1.0% from $-3.07.

Where can I find Aligos Therapeutics, Inc.'s Q3 2025 SEC filings?

You can read the 8-K earnings release (0001171843-25-007075) and the 10-Q periodic report (0001193125-25-268203) directly on SEC EDGAR. The filing index links above go to sec.gov.